Shaanxi Micot Pharmaceutical Technology – Trademark Portfolio

Entity Type: 03

Shaanxi Micot Pharmaceutical Technology holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MICOT.

Room B06, 26th Floor, Building 5,

Shenzhou Digital Science And Technology Park, No. 20 Zhangba 4th Road, High-tech Zone, Xi'an Shaanxi

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MICOT
MICOT
Registered 2022

Trademark Classifications

Shaanxi Micot Pharmaceutical Technology's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shaanxi Micot Pharmaceutical Technology have?

Shaanxi Micot Pharmaceutical Technology has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shaanxi Micot Pharmaceutical Technology file in?

Shaanxi Micot Pharmaceutical Technology files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shaanxi Micot Pharmaceutical Technology's most well-known trademarks?

Shaanxi Micot Pharmaceutical Technology's registered trademark portfolio includes well-known marks such as MICOT. These are among 1 currently registered trademark in the portfolio.

What is Shaanxi Micot Pharmaceutical Technology's trademark registration success rate?

Shaanxi Micot Pharmaceutical Technology has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.